Deciphering a function of a given protein requires investigating various biological aspects. Usually, the protein 29 of interest is expressed with a fusion tag that aids or allows subsequent analyses. Additionally, downregulation 30 or inactivation of the studied gene enables functional studies. Development of the CRISPR/Cas9 methodology 31 opened many possibilities but in many cases it is restricted to non-essential genes. It may also be time-32 consuming if a homozygote is needed. Recombinase-dependent gene integration methods, like the Flp-In 33 system, are very good alternative. The system is widely used in different research areas, which calls for the 34 existence of compatible vectors and efficient protocols that ensure straightforward DNA cloning and creation 35 of stable cell lines. We have created and validated a robust series of 52 vectors for streamlined generation of 36 stable mammalian cell lines using the FLP recombinase-based methodology. Using the sequence-independent 37 DNA cloning method all constructs for a given coding-sequence can be made with just three universal PCR 38 primers. The collection allows tetracycline-inducible expression of proteins with various tags suitable for 39 protein localization, FRET, bimolecular fluorescence complementation (BiFC), protein dynamics studies 40 (FRAP), co-immunoprecipitation, the RNA tethering assay and cell sorting. Some of the vectors contain a 41 bidirectional promoter for concomitant expression of miRNA and mRNA, so that a gene can be silenced and 42 its product replaced by a mutated miRNA-insensitive version. We demonstrate the efficacy of our vectors by 43 creating stable cell lines with various tagged proteins (numatrin, fibrillarin, coilin, centrin, THOC5, PCNA). 44
INTRODUCTION
presence of tetracycline [42, 43] . Other variants of these systems use fusions of TetR with a transcriptional 109 activator or silencer. 110
We have established a straightforward method to generate Flp-In-based cellular models for functional 111 studies of human proteins. We have created and validated a robust series of vectors designed for an efficient 112 cloning strategy that enables cheap and easy generation of DNA constructs, and we have combined the 113 efficient cloning with a Flp-In system for stable Tet-ON cell line generation. The cloning procedure has been 114 successfully applied to more than 500 DNA constructs, most of which were obtained in the first attempt. Our 115 vectors facilitate localization studies, protein purification, in vitro and in vivo protein interaction studies (co-116 IP, BiFC, FRET), protein dynamics studies (FRAP, photoactivation, etc.) and studies that involve RNA 117 tethering. We present examples of protein localization and interaction studies, including a chemical cross-118 linking approach that helps to reveal weak interactions. We have analysed transgene expression over time in 119 order to provide a guideline for future experiments. We also compare the utility of two commonly used 120 inducers for tetracycline-responsive promoters, namely tetracycline and doxycycline. 121 A subset of our vectors enables inducible downregulation of the endogenous gene of interest and 122 concomitant expression of its protein product from an exogenous allele. This approach can be useful e.g. for 123 functional validation of newly identified mutations. We used these vectors to establish a cellular model for 124 investigation of the 5'-3' exoribonuclease XRN2. Deep RNA sequencing analysis of cells devoid of the XRN2 125 ribonucleolytic activity revealed that this activity is required for transcriptional termination. Our protein 126 interaction studies confirmed previously described XRN2 interactors and revealed potential new ones. 127
Altogether our validation experiments confirm that our strategy is highly applicable for efficient creation of 128 cellular models. Our detailed protocols should ensure smooth transfer of this strategy to other laboratories. 129 pAdML-M3 [46] and the 24xMS2 stem-loop sequence came from pCR24MS2SLa kind gift of Witold 139
Filipowicz. The N-terminator peptide sequence came from plasmids described previously [47] . All vector 140 sequences are presented in Supplementary Data 2 (annotated GenBank format) as well as will be available on 141 our lab's website, http://adz.ibb.waw.pl (SnapGene format). Vectors will be made available from Addgene. 142 143
Sequence and Ligation Independent Cloning (SLIC) 144
A simplified SLIC protocol was applied [7] . Detailed description of the SLIC protocol and instructions for 145 using the pKK-RNAi backbone can be found in Supplementary Tetracyline (550205, Thermo Fisher Scientific) or doxycycline (D9891, Sigma) was added to 96% ethanol at 158 a concentration of 1-5 mg/ml, rotated for 30 minutes at room temperature and incubated overnight at -20°C. 159
On the following day the solutions were rotated again for 30 minutes at room temperature, filtered (0.22 µm) 160 and diluted with ethanol to a final concentration of 0.1 mg/ml. This stock solution (0.1 mg/ml) was stored at 161 -20°C. 162 163
Stable Cell Line Generation 164
Parental cells were plated onto 6-well plates and cultured for 24 hours. On the next day cells were co-165 transfected using 2 µl of TransIT-2020 reagent (Mirus) with 0.3 µg of gene-of-interest construct and 1.0 µg 166 of pOG44 (Thermo Fisher Scientific). Twenty four hours after transfection, cells were replated to 60 mm 167 dishes and subjected to selection with hygromycin B (50 and 175 μg/ml for 293 and HeLa cells, respectively) 168 (Thermo Fisher Scientific) and blasticidin (10 μg/ml) (Invivogen) for up to a month. A detailed day-by-day 169 protocol is described in Supplementary Data 6. Where applicable, colonies were stained with crystal violet 170 (0.5% w/v). 171 172
Western Blot 173
Total protein cell extracts were prepared as described previously [48] . Protein concentration was determined 174 by the Bradford method. The protein extracts, 20 μg per well, were separated by sodium dodecyl sulfate 175 polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to a nitrocellulose membrane (Protran, 176 Whatman GmbH). Western blotting was performed according to standard protocols using the following 177 primary antibodies: anti-EGFP (dilution 1:1000, sc-9666, Santa Cruz Biotechnology), anti-THOC5 (dilution 178 
Expression kinetics 198
Cells were plated onto 24-well plates at 50,000 cells per well. 24 hours later the cells were induced with 199 tetracycline or doxycycline at a final concentration of 100 ng/ml in 6 hour intervals. Additionally, at the time 200 of the first induction another well was plated, where the cells were induced upon plating. 24 hours after the 201 first induction the cells were detached by trypsin treatment, diluted with PBS, and analysed with a BD 202
FACSCalibur flow cytometer (BD Biosciences). A gate was applied to the FSC/SSC plot to exclude dead cells 203 and debris. 10,000 events were collected. Data were analysed using the FlowingSoftware. 204
205

Validation of XRN2 stable cell lines 206
Cells were plated onto 6-well plates at 500,000 cells per well and induced upon plating with tetracycline 207 (25 ng/ml). 24 hours later the cells were detached by trypsin treatment, washed with PBS, and analysed with 208 an Attune NxT flow cytometer equipped with 488 nm and 561 nm laser diodes (Thermo Fisher Scientific). A 209 gate was applied to the FSC/SSC plot to exclude dead cells and debris. Doublet discrimination was performed 210 based on the FSC-A/FSC-H plot. 20,000 events were collected. Data were analysed using Attune NxT 211 software. 212
213
Fluorescence Microscopy 214
Stable cell lines expressing XRN2 were analysed by the following protocol: 24 hours prior to imaging cells 215 were seeded on poly-L-lysine-coated (see below) 8-well Lab-Tek II Chambered Coverglass culture vessels 216 (155409, Thermo Fisher Scientific) at 30,000 per well and induced with tetracycline (25 ng/ml). Before 217 imaging, Hoechst 33342 dye was added to the medium (2 ng/ml) for 30 minutes to stain cell nuclei. After 218 staining medium was replaced. Images were collected using a FluoView1000 Olympus confocal system with 219 a PLANAPO 60x/1.40 oil immersion lens. Live cell imaging was performed in a temperature (37°C) and CO2 220 (5%) incubator. 221
All other stable cell lines were analyzed as follows: cells were plated onto 8-well Lab-Tek II Chambered 222
Coverglass culture vessels coated with poly-L-lysine at 7,000 (HeLa) or 10,000 (293) cells per well. 223
Tetracycline at a final concentration of 25 ng/ml was added to the medium upon plating. On the following day 224 the cells were stained with Hoechst 33342 for 30 minutes (final concentration of 50 ng/ml). Live imaging was 225 done with an FV10i system (Olympus), maintaining the cells at 37°C in a humidified 5% CO2 atmosphere 226 delivered from a The Brick gas mixer (Life Imaging Services). Fluorescence was excited with 405 and 483 227 laser diodes and collected with a SuperApochromat 60x/1.2 water immersion lens. Where applicable, Z stacks 228 were collected with 350 nm spacing. 229
230
Preparation of poly-L-lysine-coated coverglasses 231
Poly-L-lysine hydrobromide (P1274, Sigma) was dissolved in sterile water to 0.01% (w/v). The solution was 232 sterilized with a 0.22 micron filter before freezing aliquots at -20°C. Before use, the solution was thawed and 233 200 μl was added to each well of 8-well Lab-Tek II Chambered Coverglass to fully coat the surface of each 234 well. Coating was performed for 1 hour at 37°C, after that the solution was removed and coverglasses were 235 dried at room temperature for 20 minutes under a laminar flow hood. The poly-L-lysine solution was collected 236 and stored at -20°C for repeated use. Dried coverglasses were stored at room temperature or directly used for 237 cell seeding. 238
239
RNA Isolation, Library Construction and Deep-Sequencing 240
Total RNA was isolated with the TRI Reagent (T9424, Sigma) according to the manufacturer's instructions. Tris-HCl pH 8.0). In the case of DSP-treated samples purified proteins were eluted by incubation of beads in 314 3.5 volumes of pre-heated elution buffer (3% (w/v) SDS, 50 mM Tris-HCl pH 8.0, 50 mM DTT) for 10 315 minutes at 90°C. For DSP-untreated samples purified proteins were eluted with TEV protease. Beads were 316 resuspended in 3.5 volumes of TEV cleavage buffer (150 mM NaCl, 0.5 mM EDTA, 10 mM Tris-HCl pH 317 8.0, 1 mM DTT) containing TEV protease purified in our laboratory [52] and incubated for 2 hours at room 318 temperature. Regardless of elution method, eluted proteins were precipitated as described in the next section. 319 320
Protein Precipitation 321
Proteins were precipitated using the methanol-chloroform method [53] . The elution fraction was mixed with 322 4 volumes of methanol, briefly vortexed, and mixed with one volume of chloroform, after which samples were 323 briefly vortexed and 3 volumes of water were added. After vortexing samples were centrifuged for 2 minutes 324 at 14,000g at 22°C. The aqueous phase was discarded and 4 volumes of methanol were added. Samples were 325 briefly vortexed and centrifuged for 3 minutes at 14,000g at 22°C. The supernatant was discarded and the 326 pellet was dried at room temperature and stored at -20°C. 327
328
Mass spectrometry analysis 329
Precipitated proteins were dissolved in 100 μl of 100 mM ammonium bicarbonate buffer, reduced in 100 mM 330 DTT for 30 min at 57°C, alkylated in 55 mM iodoacetamide for 40 min at RT in the dark and digested 331 overnight with 10 ng/ml trypsin (V5280, Promega) at 37°C. Finally, to stop the digestion, trifluoroacetic acid 332 was added at a final concentration of 0.1%. The mixture was centrifuged at 4°C, 14,000g for 20 min to remove 333 precipitated material. MS analysis was performed by LC-MS in the Laboratory of Mass Spectrometry (IBB 334 PAS, Warsaw) using a nanoAcquity UPLC system (Waters) coupled to a LTQ-Orbitrap Velos or QExactive 335 mass spectrometer (Thermo Fisher Scientific). The mass spectrometer was operated in the data-dependent 336 MS2 mode, and data were acquired in the m/z range of 300-2000. Peptides were separated by a 180 min linear 337 gradient of 95% solution A (0.1% formic acid in water) to 35% solution B (0.1% formic acid in acetonitrile). 338
The measurement of each sample was preceded by three washing runs to avoid cross-contamination. The final 339 MS washing run was searched for the presence of cross-contamination between samples. If the protein of 340 interest was identified in the washing run and in the next measured sample at the same or smaller intensity, 341 then the identified protein was treated as cross-contamination. Data were analyzed with the Max-Quant 342 (Version 1.4.1.2) platform using mode match between runs [54]. The reference human proteome database 343 from UniProt was used (downloaded at 2015.11.20). Variable modification were set for: methionine oxidation, 344 carbamidomethyl on cysteines and reduced or alkylated part of DSP spacer arm in the case of DSP-treated 345 sample. Protein abundance was defined as the signal intensity calculated by MaxQuant software for a protein 346 divided by its molecular weight. Enrichment was defined as the ratio of the protein intensity measured in the 347 bait purification to background level (i.e., protein intensity in the negative control purification with the 348 background level arbitrarily set to 1 for proteins not detected in the negative control). 349
350
RESULTS AND DISCUSSION 351
Construction of SLIC-competent vectors 352
A new set of vectors was designed to fulfil four requirements: 1) compatibility with sequence-353 independent, straightforward and efficient cloning; 2) minimal number of primers required for cloning into 354 different vectors; 3) compatibility with FLP-mediated stable cell line generation; 4) regulated transgene 355 expression. To achieve these goals we modified the pcDNA5/FRT/TO vector (Thermo Fisher Scientific) that 356 enables FLP-mediated cell line generation and contains a tetracycline-regulated CMV promoter to drive 357 expression of the cloned CDS ( Figure S1 ). The aim of our modification was to make the vector suitable for BirA, which can be used for identification of proximal and interacting proteins; 4) other proteins, e.g. protein 367
A or maltose binding protein (MBP), for which several molecular tools are described (vectors pKK, Table 1  368 and Supplementary Data 8). The coding sequence of the protein of interest is inserted between the SLIC arms. 369
For the N-terminal fusions the initiation codon originates from the vector and the termination codon is 370 introduced within the cloned fragment, and vice-versa in the case of C-terminal fusions. The same forward 371 primer can be used to create both N-and C-terminal fusions, however, a specific reverse primer is required 372 (with or without the stop codon). Thus, only 3 primers are sufficient to prepare constructs encoding a protein 373 of interest in N-or C-terminal fusion with different tags and each tag encoded by pKK-series vectors can be 374 cleaved off with the TEV protease. Importantly, synonymous codons were used for designing of TEV-L and 375 TEV-R sequences to decrease chance of intramolecular homologous DNA recombination. 376
To extend the variety of possible functional analyses we also devised a vector with a bidirectional 377 promoter which enables simultaneous, inducible expression of two introduced genes ( Figure 1C ). To this end 378 we used the BI16 plasmid [44], a derivative of pcDNA5/FRT/TO with the original CMV promoter duplicated 379 back-to-back. The tetracycline operator sequence was maintained so that transcription in both directions is 380 regulated by the tetracycline repressor. We removed the luciferase coding sequences from BI16 and 381 redesigned the cloning sites. As a result, we created a series of pKK-BI16 vectors ( Table 1 and The cloning procedure starts with PCR amplification of a DNA fragment to be cloned using primers 391 with overhangs complementary to the SLIC arms in the vector (Figure 2 ). The PCR product has to be purified 392 from nucleotides, which inhibit the subsequent SLIC reaction. The purification method depends on the 393 specificity of the PCR reaction; all unspecific PCR products must be removed. After purification the product 394 is mixed with a linearized vector and treated with T4 DNA polymerase. In the absence of nucleotides the 395 polymerase trims 3' ends of DNA, producing sticky ends both in the vector and the PCR product ( Figure 2 ). 396
The sticky ends hybridize and form a nicked, potentially gapped, DNA molecule. After introduction to bacteria 397 such lesions are repaired by the host system ( Figure 2) . 398
In the course of our studies we used this strategy to clone 155 different protein coding sequences to 399 pKK vectors series, some fused with different tags, bringing the total number of constructed plasmids to 456, 400 a number high enough to assess the efficiency of our strategy (Table 2 ). In the analysis of cloning efficiency 401 we considered the PCR template (plasmid versus cDNA) and the number of attempts required to get designed 402 construct. The first attempt was successful in 99% of cases with a plasmid template and in 75% of cases with 403 a cDNA template (Table 2) . We were unable to obtain 16% of designed constructs. This failure resulted mostly 404 from unsuccessful PCR amplification of the insert (59 cases out of 72 unsuccessful clonings). Thus, some 405 constructs may require additional optimization steps to produce the insert. Nevertheless, the analysis 406 demonstrates the high efficiency of our strategy and points to insert preparation as the limiting step of the 407 procedure. 408 409 New vectors are competent for stable cell line generation 410
We set out to examine whether the modifications to the pcDNA5/FRT/TO backbone interfere with 411 stable cell line generation. In order to establish a baseline for FLP-mediated integration efficiency, we 412 transfected the 293 Flp-In T-REx parental cell line with the original pcDNA5/FRT/TO vector and counted the 413 number of colonies that originated from cells that had undergone FRT-targeted plasmid integration and 414 became resistant to the selection antibiotic. We tested a range of selection antibiotics concentrations as well 415
as the amounts of the targeting vector used for transfection ( Figure 3A ). We found that decreasing the 416 antibiotic concentration yields more colonies, while providing enough selective pressure to kill off non 417 transfected cells ( Figure 3A) . As for DNA amount, we found that within the examined range it had no effect 418 on the number of colonies obtained ( Figure 3A) . 419
Having optimized transfection and selection conditions, we compared stable transfection efficiency 420 between the original vector and our vectors bearing N-or C-terminal EGFP tags (pKK-EGFP-TEV and 421 pKK-TEV-EGFP, respectively). We found that our vectors produced a lower number of colonies ( Figure 3B) , 422 however, this number is enough to establish functional stable cell lines, as evidenced by our further 423 experiments (see below). We also observed that the number of colonies obtained for a given plasmid can vary 424 significantly from transfection to transfection (72 versus 46 colonies for pcDNA5/FRT/TO in Figure 3A and 425 3B, respectively), which was not due to any obvious reasons like different plasmid preparations or number of 426 cells subjected to transfection. 427
Subsequently, we verified that DNA constructs created from our vectors are suitable for stable 428 transfection. For this purpose, we obtained several constructs encoding EGFP-tagged proteins with different 429 subcellular localization and used them for stable transfection of 293 and HeLa parental cell lines. We studied 430 the localization of the exogenous proteins by live cell imaging (Figure 4 for HeLa and Figure S2 [64], was found to localize to the nucleus regardless of the tagged end (Figure 4 and Figure S2 ). 440 441
Regulation of transgene expression 442
The strong CMV promoter, often used to drive transgene transcription and present in our vectors, 443 ensures high transcription levels. This in turn can lead to massive overexpression [65], which may result in 444 artefacts such as protein mislocalization; hence it is of great importance to be able to regulate transgene 445 expression. Here, we use one of the most common inducible gene expression systems, wherein transcription 446 is controlled by elements of the tetracycline resistance operon, which relies on tetracycline or its derivative, 447 doxycycline, as inducers [66] . Notably, this regulatory system not only allows switching the transgene on or 448 off, it also grants a certain degree of quantitative control [65, 66] . To determine to what the extent gene 449 expression can be regulated, we induced transgenes with a range of concentrations of tetracycline and 450 doxycycline as they are both widely used in the literature ( Figure 5) . 451 Stable 293 cell lines producing different proteins fused to EGFP at the N-terminus were treated with 452 the inducer for 24 hours and collected for western blot analysis. The levels of fusion proteins were assessed 453 using anti-EGFP antibodies ( Figure 5A ). We found that the level of the protein of interest was the same at all 454 doxycycline concentrations tested, whereas tetracycline yielded a dose-dependent, albeit not always linear 455 response ( Figure 5A ). The maximal level of expression induced with tetracycline was similar to that observed 456 for cells treated with the lowest concentration of doxycycline ( Figure 5A ). This suggested that within the 457 tested concentrations range, tetracycline enables better fine-tuning of transgene expression. To examine this 458 issue further, we analysed expression of THOC5 in N-or C-terminal fusion with EGFP ( Figure 5B-D) . 459
We performed western blot analysis with THOC5-and EGFP-specific antibodies to compare levels of 460 endogenous and exogenous protein ( Figure 5B ). In addition, we took advantage of the fluorescent tag to 461 measure transgene expression with flow cytometry (Figure 5C and D) . Unlike western blot, where the 462 measured signal reflects the population average, flow cytometry gives quantitative output at the single cell 463 level, and therefore can discern whether the overall increase in steady-state levels of a protein results from a 464 small increase across the whole population or a large increase in a fraction of cells. In other words, flow 465 cytometry can extract information on population homogeneity, which is lost in western blot. The cytometry 466 results were in line with the western blot data: a dose-dependent response was observed for tetracycline but 467 not doxycycline ( Figure 5B-D) . Importantly, we found that expression changes on a per cell basis rather than 468 per population basis ( Figure 5C and D) . 469
Our results indicate that tetracycline is superior to doxycycline for studies that require adjustment of 470 transgene expression. On the other hand, if massive overproduction is needed, doxycycline has the advantage. 471
It is worth noting that for some transgenes it may be difficult to tune their expression to the levels comparable 472 to their endogenous counterparts. For example, we were able to achieve the endogenous level of expression 473 for the C-terminal EGFP fusion of THOC5 but not for the N-terminal fusion ( Figure 5B ). 474
The difference in biological activity of the examined inducers can be related to their different affinity 475 to TetR [42] and/or their different stability [67] . We tested differently aged tetracycline solutions and found 476 that while induction efficiency deteriorates with prolonged storage, reliable, reproducible results can be 477 obtained with solutions as old as 40 days ( Figure S3 ). Moreover, we examined a wide range of tetracycline 478 and doxycycline concentrations to see if they affect 293 cell viability ( Figure S4 ). Application of a resazurin-479 based assay did not reveal any deleterious effect of tetracycline or doxycycline treatment, even at 480 concentrations as high as 10 µg/ml, which is two orders of magnitude above the normal working range of up 481 to 0.1 µg/ml ( Figure S4 ). 482
Next, we performed a time-course experiment in order to monitor transgene expression over time. To 483 this end, we used HeLa stable cell lines expressing EGFP-tagged proteins and monitored them using flow 484 cytometry, so that population homogeneity could also be tracked. Four different transgenes were analysed 485 ( Figure 5E ). Expression of all studied transgenes is evident after 6 hours of induction and increases with time 486 until the maximum is achieved at about 24 hours after induction ( Figure 5E ). During that time cells respond 487 at different rates, i.e. population homogeneity can vary, but by the time maximum expression is achieved, 488 maximum homogeneity is as well. Notably, for all tested cells lines, a fraction of cells that do not express the 489 transgene exists. This fraction appears to depend solely on the transgene under investigation and can be 490 minimized by cell sorting, but rebuilds over time (data not shown). We also found that transgene expression 491 24 hours after induction is the same, irrespective of whether the inducer is added to a growing culture (24 492 hours after plating) or at the time of cell plating ( Figure 5E ). 493
The use of an inducible gene expression system is of great importance for studies of transgenes, the 494 expression of which can affect cell fitness and viability. In these cases, it is crucial to keep transgene 495 expression as low as possible under non-induced state. A common concern is that serum can contaminate 496 culture media with tetracycline or its derivatives, and it is thus usually recommended that specially tested 497 tetracycline-free grade (Tet-free) FBS is used. Such serum is much more expensive than regular one and can 498 greatly increase the cost of prolonged or large-scale culture. We decided to test the alleged superiority of Tet-499 free FBS to regular FBS in terms of the basal level of transgene expression. To this end, we generated stable 500 293 Flp-In T-REx cells expressing firefly and renilla luciferase and assessed the activity of the enzymes in 501 uninduced cells cultured in media prepared with regular FBS or certified Tet-free FBS obtained from two 502 different vendors. As a control, we treated cells with three different concentrations of tetracycline, including 503 25 ng/ml, which resulted in a maximum transgene expression in our previous experiments. We did not observe 504 any differences in basal expression of the transgenes (Figure 6 ), but we did find differences in induced 505 expression: cells cultured in medium supplemented with regular FBS achieved higher transgene expression 506 upon induction with 5 and 25 ng/ml tetratycline than likewise treated cells cultured in medium containing Tet-507 free FBS. The obtained results suggest that there is no clear benefit from using Tet-free FBS in terms of leaky 508 expression. However, it is important to note that FBS can vary from batch to batch and it is prudent to pre-test 509 every lot of standard FBS for its suitability for tetracycline-based expression systems. 510 511 Stable cell lines are suitable for functional studies 512
Describing the protein-protein interaction network is an important step of establishing any protein's 513 function. To demonstrate the capabilities of our experimental model in this respect we searched for proteins 514 that co-purify with the exoribonuclease XRN2, a protein involved in RNA polymerase II (RNAPII) 515 transcription termination and other important aspects of RNA metabolism [68, 69, 70, 71] . Some protein 516 partners of human XRN2 have been described that can be used as a control in our co-purification studies 517 (Supplementary Data 9, 'Known interactors' sheet) [69, 72, 73, 74, 75, 76, 77, 78, 79, 80] . To identify weak 518 and/or transient interactions we applied a strategy that involves in vivo protein cross-linking [81] . In this 519 approach, which to the best of our knowledge has not been used in studies of XRN2, protein-protein 520 interactions are stabilized by introduction of a covalent bond between proteins. 521 There are several cross-linkers available that differ in length, membrane permeability and reversibility 522 of the cross-linking. We used dithiobis(succinimidyl propionate) (DSP), which is membrane permeable and 523 contains a disulfide bond in its spacer arm that can be broken using a reducing agent like 2-mercaptoethanol 524 (BME). Since over-cross-linking can result in large, insoluble protein complexes and hamper protein 525 identification with mass spectrometry, we performed a preliminary test in order to establish optimal cross-526 linking conditions (Figure 7) . 293 Flp-In T-REx cells were treated with a range of DSP concentrations for two 527 different periods of time and corresponding protein extracts were subjected to western blot analysis using 528 denaturing non-reducing conditions followed by HSP60 detection. HSP60 is known to form an oligomer [82], 529 which makes it a good positive control for protein cross-linking because its cross-linked oligomeric form 530 should be resistant to SDS-PAGE denaturing conditions. 531
Cross-linking should manifest in decreased levels of the normal band of the protein of interest, 532 corresponding to its monomeric form, with concomitant appearance of higher molecular weight species. Our 533 aim was to find conditions in which the cross-linking is clearly detectable, but does not apply to the entire 534 pool of the monitored protein. As a control, fractions of protein samples were reduced with BME before 535 electrophoresis. Higher molecular weight species representing cross-linked HSP60 oligomers were detected 536 when cells were treated with 0.3 mM or higher concentrations of DSP (Figure 7) . A monomeric form of the 537 protein was observed over the whole range of tested DSP concentrations, however, its level was reduced in 538 samples where cross-linked species were detected (Figure 7) . The persistence of monomeric HSP60 despite 539 DSP-treatment may be caused by the fact that HSP60 is highly abundant in the cell and may require extended 540 treatment in order to achieve complete cross-linking. Nevertheless, this results show that DSP-treatment can 541 stabilize protein complexes. Importantly, we confirmed that applying reducing conditions reverses DSP cross-542 linking (Figure 7, sample treated with BME) . The conditions which we found to be most suitable (15 minutes 543 of treatment, 0.3-0.5 mM DSP) are consistent with those suggested by others [81] . 544
To perform identification of XRN2 protein partners, we generated stable 293 Flp-In T-REx cell lines 545 that inducibly express XRN2 fused with EGFP at its N-or C-terminus. Using fluorescence microscopy, we 546 confirmed the expected nuclear localization of the fusion proteins ( Figure 8A ). Subsequently, cells were 547 subjected to DSP cross-linking or not, and collected in order to conduct EGFP affinity purification. The 548 parental cell line was used as a negative control. Purified proteins were identified by mass spectrometry and 549 quantified using a label-free approach. In total, we identified 891 proteins (Supplementary Data 9, 'Initial list' 550 sheet). The initial list of identified proteins was trimmed (Supplementary Data 9, 'Removed' sheet) by 551 applying the following criteria: 1) remove proteins that were identified in control samples but were absent in 552 samples from cells expressing exogenous XRN2; 2) ignore proteins that are found to be common 553 contaminations; 3) disregard proteins that were identified in only one of four XRN2 pull-downs; 4) omit 554 proteins that localize to mitochondria (present in MitoCarta 2.0, [83]). Eventually, we obtained a list of 397 555 proteins (Supplementary Data 9, 'Final list' sheet) that were divided into two groups: proteins identified in 556 the RNA-binding proteome [20] and others ( Figure 8B , circles and squares, respectively). Importantly, the 557 final list contained proteins that were previously shown to interact with XRN2 ( Figure 8B , blue marks, list of 558 known interactors is shown in Supplementary Data 9, sheet 'Known interactors'). CDKN2AIPNL, which is 559 known to stabilize XRN2 [72] was on the top of the list. We also identified DHX15 helicase, which has been 560 recently described as direct interactor of XRN2 [80] . The presence of these well-established XRN2 interactors 561 in elution fractions indicated that the applied procedure is eligible for identification of XRN2 partners. Proteins 562 that were enriched (enrichment log10 ≥ 1) in at least three out of four XRN2 purifications were considered 563 potential new interactors of XRN2 ( Figure 8B , red figures; Supplementary Data 9, 'Potential new interactors' 564 sheet). These interactions require further validation, nevertheless their list provide valuable information for 565 future studies of molecular mechanisms that depend on XRN2. 566
Notably, some proteins co-purified with XRN2 only in DSP-treated samples. Proteins that were 567 enriched (enrichment log10 ≥ 1) in both DSP cross-linked samples but not in their non-cross-linked 568 counterparts were regarded as DSP-specific ( Figure 8B, black figures) . This group can constitute transient or 569 weak interactors of XRN2. Again, their interactions with XRN2 need further experimental support. 570
Nonetheless, these results indicate that stable cell lines created by using our strategy are applicable to 571 functional studies. 572
573
Vectors for simultaneous expression of mRNA and miRNA 574
One of the most important approaches in discovering gene function is its downregulation so that the 575 respective protein product is depleted. This can be achieved by several experimental strategies that differ in 576 downregulation efficiency and the effort required. A complete inactivation of a gene by its deletion or 577 insertional inactivation has a strong advantage in terms of downregulation, but can be laborious if the gene of 578 interest is essential. Alternatively, expression of the gene can be downregulated by RNA interference (gene 579 silencing). This is a straightforward strategy, in which short RNA molecules complementary to a particular 580 mRNA target it for degradation or repress its translation [84] . Unlike gene disruption, this approach can target 581 specific isoforms but has a major drawback in the risk of off-target activity of the short RNA. Therefore, in 582 this kind of experiments it is very important to introduce controls that confirm that the observed phenotypes 583 are bona fide effects of downregulation of the gene of interest [85]. One such control is a "rescue" sample, in 584 which an exogenous, RNAi-resistant allele of the gene in question is expressed, while the endogenous one is 585 silenced. A simple rescue sample is obtained by transient co-transfection with siRNA and plasmid DNA, 586 however, this may suffer from a range of problems, like irreproducibility, imperfect co-transfection, and 587 transfection-related cell stress. 588
To create a straightforward tool for RNAi-based rescue experiments, we designed the pKK-RNAi 589 vector series (Table 1, Figure 9A ), derived from pKK-BI16. The logic behind these vectors was previously 590 described by us in studies concerning the catalytic subunits of the exosome complex [86, 87] and other 591 nucleases [88, 89] . We use plasmids with a bidirectional promoter in order to concurrently express two genes: 592 1) a cassette encoding miRNAs that target the gene of interest, and 2) an allele of the gene of interest with the 593 protein coding sequence harbouring silent mutations that make the mRNA insensitive to the miRNAs (Figure  594 9B). As a result, the endogenous alleles of the gene are silenced, whereas the exogenous copy is expressed 595 ( Figure 9B ). Furthermore, the miRNAs are cotranscriptionally expressed with a fluorescent protein reporter 596 so that analysis can be narrowed down to cells that express miRNA, provided that applied assay can distinguish 597 cells expressing reporter (Figure 9) . 598
The pKK-RNAi vectors apply cloning procedure ( Figure S5 and Supplementary Data 4), simpler than 599 the previous one [86] , which involved multiple steps and was strongly dependent on the target sequences. 600
Both inconveniences were reduced as much as possible in the new vectors. We also improved the utility of 601 the miRNA expression reporter by adding the SV40 nuclear localisation signal to the fluorescent reporter. It 602 is now more concentrated and as such easier to detect with fluorescent microscopy (stronger fluorescent signal 603 per area unit), and can be used as a nuclear marker which can be of great value for example for studies that 604 involve image analysis. If necessary, the fragment encoding the miRNA expression reporter can be removed 605 or substituted by restriction enzyme cloning. Notably, the region where the exogenous protein-coding 606 sequence is inserted originates from pKK vectors, which ensures compatible cloning strategies. 607
We created several pKK-RNAi vectors with different miRNA reporters and fusion tags for the protein 608 of interest (Table 1 and Supplementary Data 8). So far we have used these vectors to create 50 miRNA-609 encoding constructs, which were obtained by subcloning of the miRNA cassette, for 27 genes (Table 3) . 45 610 of these constructs were further modified by insertion of CDS with silent mutations (Table 4 ). This step was 611 performed by splice-PCR which is thoroughly described in Supplementary Data 4. The majority of constructs 612 were obtained in the first attempt (Table 3 and 4), which highlights the high efficiency of our cloning 613 procedure ( Figure S5 and Supplementary Data 4). All subcloning of miRNA cassettes required only one 614 attempt to obtain the correct construct (Table 3) , whereas in the case of CDS cloning the first attempt was 615 successful in almost 90% (Table 4) . Notably, the number of plasmids that had to be sequenced to obtain a 616 correct construct indicates that this is not the rate-limiting step (Table 3 and 
4). 617
To test the pKK-RNAi cellular model in functional studies we analysed the effect of depriving the cell 618 of the catalytic activity of the nuclear 5' to 3' exoribonuclease XRN2. Catalytic amino acids in this protein 619 had been defined previously, so it was possible to design a mutated catalytically inactive form of the protein 620 (XRN2 D233A-D235A ) [90] . We created 293 Flp-In T-REx stable cell lines that induciby silence endogenous 621 XRN2, and concomitantly express wild-type or inactive XRN2 in fusion with EGFP at the C-terminus. Thus, 622 complementation of silencing of endogenous XRN2 with the expression of mutant version of the protein 623 allows to directly link potential phenotypes with the lack of XRN2 enzymatic activity. Flow cytometry 624 analysis showed that almost all cells expressed the miRNA reporter (mCherry) and the exogenous protein 625 (EGFP signal) ( Figure 10A ). We confirmed correct subcellular localization of the exogenous proteins by 626 confocal microscopy. This analysis revealed their anticipated nuclear localization ( Figure 10B ). Subsequently, 627
we examined the efficiency of XRN2 downregulation at the protein level. It showed very efficient depletion 628 of XRN2, which was hardly detectable ( Figure 10C ), while the exogenous forms of XRN2 were expressed, 629 importantly, at levels similar to that of endogenous XRN2 in parental cells ( Figure 10C) . 630
It was shown that human XRN2 is a bona fide component of the transcription termination machinery 631 [68, 71] . We checked if it is possible to reproduce this observation using our experimental system. To this end 632 we isolated total RNA from tetracycline-treated cells, depleted it from rRNA and conducted strand-specific 633 deep sequencing. A meta-gene analysis of the transcriptional read-through was performed ( Figure 10D ). In 634 agreement with other reports [68, 71], we found that the ribonucleolytic activity of XRN2 is required for 635 RNAPII transcription termination. A clear accumulation of transcripts resulting from unsuccessful termination 636 events was observed in cells that expressed inactive, miRNA-insensitive XRN2 instead of the endogenous 637 protein ( Figure 10D ). This class of transcripts is clearly less abundant in cells that express the catalytically 638 active form of XRN2. This indicates that the cellular model which we obtained using pKK-RNAi vectors is 639 functional and faithfully reproduces independent experiments obtained by others using different methods. 640
Taken together, our analysis of cloning efficiency and performed functional studies indicate that pKK 641 can produce a more homogenous cell population and result in a higher overall silencing efficiency. 657
In agreement with previous report [66] we observed that doxycycline is more effective in gene 658 induction than tetracycline. This can be detrimental when fine-tuning transgene expression is required, as 659 small differences in the inducer concentration can cause significant differences in transgene expression. 660
Although expressed transgenes respond to tetracycline in a concentration-dependent manner, the expression 661 level can be transgene-specific, which is likely related to the stability of particular fusion proteins or their 662 mRNAs. Therefore, the response of each transgene should be tested; the concentrations we used can serve as 663 a guideline. 664
Using our experimental approach, we confirmed the involvement of XRN2 in RNAPII transcriptional 665 termination. Our interaction studies are in agreement with previous reports; however, we have also revealed 666 pKK-TEV-FLAG C-terminus see above pKK-TEV-3XFLAG C-terminus see above [129, 130, 131] pKK-TEV-HA C-terminus see above pKK-TEV-FLAG-BirA C-terminus see above pKK-TEV-MBP C-terminus see above pKK-TEV-ProteinA C-terminus two IgG binding domains of Staphylococcus aureus Protein A [132] pKK-TEV-mTagBFP C-terminus see above pKK-TEV-mCerulean C-terminus see above pKK-TEV-mVenus C-terminus see above pKK-TEV-mAmber C-terminus see above pKK-TEV-EGFP C-terminus see above pKK-TEV-mEGFP C-terminus see above pKK-TEV-mClover3 C-terminus see above pKK-TEV-mCherry C-terminus see above pKK-TEV-mRuby3 C-terminus see above pKK-TEV-mCardinal C-terminus see above pKK-TEV-CyOFP1 C-terminus see above pKK-TEV-Dendra2N C-terminus see above
pKK-BI16 Vector Series
pKK-BI16-TEV-mCherry C-terminus one protein is expressed with mCherry fusion tag, cleavable by TEV protease; second tag introduced by user pKK-BI16-FLAG-3C-ORF1_mClover3-TEV-ORF2 both at N-terminus one protein expressed with FLAG fusion tag, cleavable by 3C protease (PreScission) or enterokinase; second protein expressed with mClover3 fusion tag, cleavable by TEV protease pKK-BI16-ORF1-3C-mRuby3_ORF2-TEV-mClover3 both at C-terminus one protein expressed with mRuby3 fusion tag, cleavable by 3C protease (PreScission); second protein expressed with mClover3 fusion tag, cleavable by TEV protease pKK-BI16-ORF1-3C-FLAG_ORF2-TEV-mClover3 both at C-terminus one protein expressed fusion with FLAG fusion tag, cleavable by 3C protease (PreScission); second protein expressed with mClover3 fusion tag, cleavable by TEV protease 
pKK-BiFC Vector Series
